Irritable bowel syndrome immune hypothesis. Part two: The role of cytokines;Hipótesis inmune del síndrome del intestino irritable. Segunda parte: Papel de las citokinas

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 12, 2010, Pages 711-717

  Ortiz Lucas, María ^a   Saz Peiro P ^a   Sebastian Domingo J J ^b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL ROYO VILLANOVA   (Spain)

Author keywords

Cytokines; Immune system; Interleukins; Irritable bowel s ndrome; Psychoneuroimmunology; Systematic review

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD ANALYSIS; CASE CONTROL STUDY; COLON MUCOSA; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; IRRITABLE COLON; OUTCOME ASSESSMENT; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL;

EID: 79551631494     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010001200006     Document Type: Article

References (25)

1. Ortiz Lucas M, Saz Peiró P, Sebastián Domingo JJ. Hipótesis inmune del síndrome del intestino irritable. Primera parte: papel de los linfocitos y mastocitos. Rev Esp Enferm Dig 2010; 102: 637-47.
2. Clarke M, Oxman AD, editores. Formulating the problem. Manual del Revisor Cochrane 4.1.6 [actualización enero 2003]. Section 4. En: The Cochrane Library, Número 1, 2003. Oxford: Update Software. Actualizado trimestralmente.
3. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
4. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005; 128(3): 541-51.
5. Khan I, Collins SM. Is there an inflammatory basis for a subset of patients presenting with diarrhoea in the irritable bowel syndrome? Gastroenterology 1994; 105(Supl. 2): A523.
6. Motzer SA, Jarrett M, Heitkemper MM, Tsuji J. Natural killer cell function and psychological distress in women with and without irritable bowel syndrome. Biol Res Nurs 2002; 4(1): 31-42.
7. Gwee KA, Collins SM, Read NW, Rajnakova A, Deng Y, Graham JC, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut 2003; 52 (4): 523-6.
8. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut 2003; 52 (1): 91-3.
9. Wang LH, Fang XC, Pan GZ. Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004; 53 (8): 1096-101.
10. Elsenbruch S, Holtmann G, Oezcan D, Lysson A, Janssen O, Goebel MU, et al. Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome? Am J Gastroenterol 2004; 99 (4): 703-10.
11. van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome. Am J Gastroenterol 2005; 100 (11): 2510-6.
12. Öhman L, Isaksson S, Lundgren A, Simrén M, Sjövall H. A contralled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3 (10): 980-6.
13. Dinan TG, Quigley EM, Ahmed SM, Scully P, O'Brien S, O'Mahony L, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006; 130 (2): 304-11.
14. Lucas A, Cobelens PM, Kavelaars A, Heijnen CJ, Holtmann G, Haag S, et al. Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission. J Neuroimmunol 2007; 182 (1-2): 195-203.
15. Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132 (3): 913-20.
16. Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, et al. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol 2008; 43 (12): 1467-76.
17. Dinan TG, Clarke G, Quigley EM, Scott LV, Shanahan F, Cryan J, et al. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008; 103 (10): 2570-6.
18. Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, et al. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil 2009; 21 (2): 149-59.
19. Kindt S, Van Oudenhove L, Broekaert D, Kasran A, Ceuppens JL, Bossuyt X, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil 2009; 21 (4): 389-98.
20. Öhman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, et al. T-cell activation in patients with irritable bowel syndrome. Am J Gastroenterol 2009; 104 (5): 1205-12.
21. Schmitz T, Chew LJ. Cytokines and myelination in the central nervous system. Scientific World Journal 2008; 8: 1119-47.
22. Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 2008; 19 (1): 41-52.
23. Guyon A, Massa F, Rovère C, Nation JL. How cytokines can influence the brain: a role for chemokines? J Neuroimmunol 2008; 198 (1-2): 46-55.
24. Elenkov IJ, Chrousos GP. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. Trends in Endocrinology and Metabolism 1999; 10(9): 359-68.
25. a edición. Barcelona; 2008.